According to the NIH, it is seeking proposals that will help develop resources to identify subpopulations of patients exposed to an infectious agent who are likely to develop infection-associated cancer.
"Identifying these subpopulations has proven difficult," the NIH said. "Molecular markers provide a potential tool to identify the at-risk subpopulation and the presence of early stage cancers. This initiative encourages research to identify proteomic markers for risk assessment and early detection in individuals exposed to infectious agents that have been linked to cancer."
The NIH said that while it will fund select research projects, "because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary." The agency added that no funds have been specifically earmarked for the program, but that "awards pursuant to this funding opportunity are considered of high programmatic significance for funding consideration."
The National Cancer Institute and the National Institute of Dental and Craniofacial Research are the participating institutes on this funding opportunity.
Additional details can be found here.